Literature DB >> 26554918

Metamorphopsia: An Overlooked Visual Symptom.

Edoardo Midena1, Stela Vujosevic.   

Abstract

Metamorphopsia is a common symptom in different macular disorders. Micropsia and macropsia are special types of metamorphopsia. Recent theories suggest that both retinal and cortical mechanisms are involved in the development and changes of metamorphopsia. Different functional tests have been proposed for the evaluation of metamorphopsia: from the Amsler grid to the hand-held mobile devices for home monitoring. This review addresses some new insights into the pathophysiology of metamorphopsia and different available tests for the evaluation of this symptom in most common macular disorders. The importance of quantification of metamorphopsia in macular diseases is confirmed by the most recent therapeutic approaches.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26554918     DOI: 10.1159/000441033

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  12 in total

1.  Correlation between tangential distortion of the outer retinal layer and metamorphopsia in patients with epiretinal membrane.

Authors:  Daiki Sakai; Seiji Takagi; Yasuhiko Hirami; Makoto Nakamura; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-16       Impact factor: 3.117

2.  Metamorphopsia associated with central retinal vein occlusion.

Authors:  Koichiro Manabe; Rie Osaka; Yuki Nakano; Yukari Takasago; Tomoyoshi Fujita; Chieko Shiragami; Kazuyuki Hirooka; Yuki Muraoka; Akitaka Tsujikawa
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

3.  Persistent metamorphopsia associated with branch retinal vein occlusion.

Authors:  Rie Osaka; Koichiro Manabe; Saki Manabe; Yuki Nakano; Yukari Takasago; Chieko Shiragami; Kazuyuki Hirooka; Yuki Muraoka; Akitaka Tsujikawa
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

4.  THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters.

Authors:  SriniVas R Sadda; Pravin U Dugel; Victor H Gonzalez; Esmeralda Meunier; Petra Kozma
Journal:  Retina       Date:  2019-02       Impact factor: 4.256

5.  Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study.

Authors:  Praveen J Patel; David H Steel; Christoph Hirneiß; John Brazier; Abdalla Aly; Benedicte Lescrauwaet
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

6.  Correction of perceived visual distortions using a software application and correlation to age-related macular degeneration.

Authors:  Muhammad Hassan; Adithi D Chakravarthy; Mahadevan Subramaniam; Parvathi Chundi; Mohammad Ali Sadiq; Muhammad Sohail Halim; Rubbia Afridi; Anh N T Tran; Yasir J Sepah; Diana V Do; Quan Dong Nguyen
Journal:  Ther Adv Ophthalmol       Date:  2020-05-18

Review 7.  Recent Advances of Computerized Graphical Methods for the Detection and Progress Assessment of Visual Distortion Caused by Macular Disorders.

Authors:  Navid Mohaghegh; Ebrahim Ghafar-Zadeh; Sebastian Magierowski
Journal:  Vision (Basel)       Date:  2019-06-05

8.  Metamorphopsia Associated with Branch Retinal Vein Occlusion.

Authors:  Koichiro Manabe; Akitaka Tsujikawa; Rie Osaka; Yuki Nakano; Tomoyoshi Fujita; Chieko Shiragami; Kazuyuki Hirooka; Akihito Uji; Yuki Muraoka
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

9.  Validation of a novel functional test for assessing metamorphopsia using epiretinal membranes as a model.

Authors:  Henrietta Wang; Sieu K Khuu; Sheila Lam; Clarissa Lin; Michael Kalloniatis; Jack Phu
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

10.  Multi-line Adaptive Perimetry (MAP): A New Procedure for Quantifying Visual Field Integrity for Rapid Assessment of Macular Diseases.

Authors:  Steven M Thurman; Marcello Maniglia; Pinakin G Davey; Mandy K Biles; Kristina M Visscher; Aaron R Seitz
Journal:  Transl Vis Sci Technol       Date:  2018-10-16       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.